Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Advantages of robotic surgery for advanced gastric cancer in short-term outcomes: A single-center retrospective study using propensity score matching.
Authors
Masaru Komatsu
National Cancer Center Hospital East, Kashiwa, Japan
Masaru Komatsu , Masahiro Yura , Mitsumasa Yoshida , Takumi Habu , Hiromi Nagata , Takahiro Kinoshita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 343)
DOI
10.1200/JCO.2024.42.3_suppl.343
Abstract #
343
Poster Bd #
G4
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Significance of intratumoral tertiary lymphoid structure (TLS) as predictictive factors of nivolumab therapy after conversion surgery for unresectable gastric cancer: A retrospective study.
First Author: Hiroaki Tanaka
Poster
2013 Gastrointestinal Cancers Symposium
Prognostic factors after R2 surgery in patients with advanced gastric cancer.
First Author: Masanori Tokunaga
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of trastuzumab deruxtecan and nivolumab as third- or later-line treatment for HER2-positive advanced gastric cancer: A single-institution retrospective study.
First Author: Keitaro Shimozaki
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.
First Author: Yusuke Amanuma